Published in J Hepatol on January 01, 1986
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med (1998) 9.03
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology (1987) 3.65
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology (2000) 3.58
Foreign body aspiration into the lower airway in Chinese adults. Chest (1997) 3.54
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology (2001) 2.72
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology (2001) 2.51
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology (2000) 2.26
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma. Hepatology (1989) 2.20
Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology (1998) 2.19
Variants of the adenomatoid odontogenic tumor with a note on tumor origin. J Oral Pathol Med (1992) 1.84
Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer (1988) 1.83
Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology (1979) 1.81
Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology (1999) 1.80
Clear cell carcinoma of liver. An ultrastructural study. Cancer (1983) 1.72
Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat (2001) 1.70
Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology (2000) 1.69
Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology (1993) 1.63
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology (1997) 1.62
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. J Hepatol (1990) 1.59
Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut (1997) 1.47
Necrotizing enterocolitis in neonates with symptomatic congenital heart disease. J Pediatr (1988) 1.46
A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology (1992) 1.44
Hepatocarcinogenesis. Trop Gastroenterol (1990) 1.44
Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol (1992) 1.44
Histologic prognostic indicators in hepatocellular carcinoma. Cancer (1979) 1.43
Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol (1985) 1.43
Synergism of chronic alcoholism and hepatitis B infection in liver disease. J Gastroenterol Hepatol (1991) 1.40
Granulocytic sarcoma presenting as bleeding gastric polyp. Pathology (1989) 1.40
A patient with large granular lymphocytosis of unusual phenotype and polymorphic T-cell receptor beta-chain gene rearrangement. Am J Clin Pathol (1990) 1.40
Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut (1983) 1.40
Cholestatic jaundice caused by sequential carbimazole and propylthiouracil treatment for thyrotoxicosis. Hong Kong Med J (2003) 1.38
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol (1996) 1.35
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.34
Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology (1987) 1.33
Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection. Hepatology (2001) 1.32
Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31
Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J Clin Microbiol (1999) 1.29
Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology (1988) 1.28
Inflammatory pseudotumour of the mouth and maxilla. J Clin Pathol (1996) 1.28
Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology (2000) 1.27
Occult hepatitis B virus infection: a hidden menace? Hepatology (2001) 1.26
High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology (1996) 1.25
Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology (1999) 1.25
Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol (1987) 1.24
Treatment of chronic hepatitis B. Lancet Infect Dis (2001) 1.22
Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet (1987) 1.20
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci (1991) 1.20
Hepatic veno-occlusive disease due to toxic alkaloid herbal tea. Lancet (1983) 1.20
Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer (1981) 1.19
In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm (2001) 1.19
Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci (1987) 1.18
Cell division of Escherichia coli: control by membrane organization. J Bacteriol (1973) 1.18
Ovarian sex cord tumor with annular tubules: a report of six cases. Gynecol Oncol (1993) 1.16
Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma. Cancer (2001) 1.16
Health-related quality of life of Southern Chinese with chronic hepatitis B infection. Health Qual Life Outcomes (2009) 1.16
Desmoplastic variant of ameloblastoma in Chinese patients. Br J Oral Maxillofac Surg (1998) 1.15
Natural history of chronic hepatitis B virus infection. J Gastroenterol Hepatol (2000) 1.15
Osteochondroma of the coronoid process of the mandible. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol (1993) 1.12
Hepatitis B infection in patients with lymphomas. Hematol Oncol (1991) 1.12
Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol (1991) 1.12
Effect of cimetidine on gonadal function in man. Br J Clin Pharmacol (1982) 1.11
Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut (2001) 1.11
Naturally occurring hepatitis B virus core gene mutations. Hepatology (1995) 1.10
Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B. J Viral Hepat (1999) 1.10
Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology (1998) 1.09
An autopsy study of hepatocellular carcinoma in Hong Kong. Pathology (1981) 1.09
Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci (1998) 1.09
Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med (1989) 1.09
The role of hepatic arterial embolization in the treatment of spontaneous rupture of hepatocellular carcinoma. Clin Radiol (1998) 1.08
Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet (1988) 1.08